glp-1 microdose Microdosing for Weight Loss Microdosing GLP-1s: Risks & Considerations

Now, pharmaceutical companies are racing to develop pill-based alternatives that may be easier to use than injections

Increasing investments in metabolic disease research, expanding clinical development programs, and continuous advancements in small-molecule drug discovery technologies are further accelerating market growth

Proper needle length selection and technique education from healthcare providers ensures optimal drug delivery

Pancreatic safety of incretin-based drugsFDA and EMA assessment

Some are approved by the US Food and Drug Administration (FDA) just for weight loss, along with healthy lifestyle changes, including a reduced-calorie diet and increased physical activity

22% of American adults said they found the cost very difficult to manage, with a similar share among insured users (23%)